Skip to main content

Want a detailed portfolio tracker?

Macrogenics (MGNX) P/E (2013 - 2026)

Macrogenics (MGNX) P/E from Dec 31, 2013 to Jul 21, 2026. The TTM Macrogenics (MGNX) P/E is -4.09. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Macrogenics (MGNX)

YearP/EChange
2026-4.09+200.28%
2025-1.36-55.14%
2024-3.04-125.37%
202311.97-654.03%
2022-2.16-55.19%
2021-4.82-47.95%
2020-9.26+164.45%
2019-3.50+16.45%
2018-3.01-29.38%
2017-4.26-68.45%
2016-13.50-78.82%
2015-63.75+150.16%
2014-25.48-88.16%
2013-215.15N/A

Comparison Macrogenics (MGNX) P/E with competitors

Macrogenics (MGNX) P/E is -4.09.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.04%
NBYStablecoin Development Corp0.00-100.11%
ENLVEnlivex Ltd0.07-101.83%
FGENFibroGen Inc0.24-105.87%
CHRSCoherus Biosciences Inc0.85-120.74%
FBIOFortress Biotech Inc0.95-123.19%
ORMPOramed Pharmaceuticals Inc1.50-136.73%
AGENAgenus Inc3.01-173.55%
INVAInnoviva Inc3.15-177.08%
VXRTVaxart Inc3.55-186.76%
CRMDCorMedix Inc3.63-188.68%
CVACCureVac N.V.4.45-208.65%
GLPGGalapagos NV4.86-218.75%
SRPTSarepta Therapeutics Inc4.88-219.32%
ABEOAbeona Therapeutics Inc5.39-231.67%
ABUSArbutus Biopharma Corp5.60-236.76%
ZVRAZevra Therapeutics Inc5.89-243.88%
SPROSpero Therapeutics Inc6.23-252.22%
CGENCompugen Ltd6.31-254.31%
RIGLRigel Pharmaceuticals6.87-267.95%
SLXNSilexion Therapeutics Corp7.30-278.32%
OMEROmeros Corporation9.26-326.28%
AUPHAurinia Pharmaceuticals Inc9.58-334.26%
PLXProtalix BioTherapeutics Inc10.89-366.17%
ACADAcadia Pharmaceuticals Inc11.73-386.64%
TBPHTheravance Biopharma Inc12.26-399.69%
ADMAAdma Biologics Inc12.42-403.50%
HRMYHarmony Biosciences Holdings Inc13.82-437.76%
SABSSAB Biotherapeutics Inc14.14-445.49%
NAGENiagen Bioscience Inc14.82-462.15%
INCYIncyte Corp15.82-486.70%
REGNRegeneron Pharmaceuticals Inc15.86-487.54%
PBYIPuma Biotechnology Inc17.32-523.19%
CPRXCatalyst Pharmaceuticals Inc17.44-526.22%
EXELExelixis Inc17.54-528.63%
TGTXTG Therapeutics Inc18.97-563.53%
MDXGMimedx Group Inc20.55-602.30%
XOMAXOMA Royalty Corp22.87-659.07%
ARGXArgen X SE24.30-693.86%
CTMXCytomX Therapeutics Inc24.82-706.64%
XOMAOXOMA Royalty Corp25.34-719.44%
HALOHalozyme Therapeutics Inc25.62-726.26%
XOMAPXOMA Royalty Corp25.67-727.39%
VRTXVertex Pharmaceuticals Inc27.99-784.21%
RPRXRoyalty Pharma plc - Class A28.69-801.14%
SLNOSoleno Therapeutics Inc29.02-809.15%
ASNDAscendis Pharma A/S30.09-835.31%
LGNDLigand Pharmaceuticals Inc - Class B37.91-1026.59%
APLSApellis Pharmaceuticals Inc39.02-1053.70%
BMRNBiomarin Pharmaceutical Inc42.21-1131.68%
KRYSKrystal Biotech Inc45.34-1208.22%
ONCBeiGene Ltd69.54-1799.61%
PHARPharming Group N.V.75.03-1933.67%
TECHBio-Techne Corp101.96-2591.92%
VCELVericel Corp109.92-2786.54%
ALNYAlnylam Pharmaceuticals Inc117.96-2983.14%
GMABGenmab140.29-3528.79%
TLXTelix Pharmaceuticals Ltd162.15-4063.11%
CORTCorcept Therapeutics Inc212.86-5302.37%